{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:35:51Z","timestamp":1786988151495,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ejps.2018.05.009","type":"journal-article","created":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T02:59:07Z","timestamp":1526439547000},"page":"200-209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"special_numbering":"C","title":["Dissolving polymeric microneedle arrays for enhanced site-specific acyclovir delivery"],"prefix":"10.1016","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1354-2648","authenticated-orcid":false,"given":"Boonnada","family":"Pamornpathomkul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanasait","family":"Ngawhirunpat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismaiel A.","family":"Tekko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalitkumar","family":"Vora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen O.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0766-4147","authenticated-orcid":false,"given":"Ryan F.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2018.05.009_bb0005","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.colsurfb.2015.10.045","article-title":"Formulation and evaluation of nano based drug delivery system for the buccal delivery of acyclovir","volume":"136","author":"Al-Dhubiab","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ejps.2018.05.009_bb0010","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejps.2017.04.001","article-title":"Statistically optimized fast dissolving microneedle transdermal patch of meloxicam: a patient friendly approach to manage arthritis","volume":"104","author":"Amodwala","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.05.009_bb0015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0190-9622(88)70025-0","article-title":"Adverse reactions to acyclovir: topical, oral, and intravenous","volume":"18","author":"Arndt","year":"1988","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejps.2018.05.009_bb0020","series-title":"Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis","author":"Arvin","year":"2007"},{"issue":"Suppl B","key":"10.1016\/j.ejps.2018.05.009_bb0025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/jac\/18.Supplement_B.75","article-title":"Clinical and laboratory experience with acyclovir-resistant herpes viruses","volume":"18","author":"Barry","year":"1986","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejps.2018.05.009_bb0030","series-title":"Goodman and Gilman's the Pharmacological Basis of Therapeutics","author":"Brunton","year":"2011"},{"key":"10.1016\/j.ejps.2018.05.009_bb0035","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijpharm.2015.04.076","article-title":"Potential of hydrogel-forming and dissolving microneedles for use in paediatric populations","volume":"489","author":"Caffarel-Salvador","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.05.009_bb0040","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jconrel.2012.01.042","article-title":"Microneedle technologies for (trans)dermal drug and vaccine delivery","volume":"161","author":"van der Maaden","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2018.05.009_bb0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijpharm.2017.04.066","article-title":"Formulation and characterisation of dissolving microneedles for the transdermal delivery of therapeutic peptides","volume":"526","author":"Dillon","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.05.009_bb0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11095-010-0169-8","article-title":"Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique","volume":"28","author":"Donnelly","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.05.009_bb0055","series-title":"Physicochemical Principles of Pharmacy","author":"Florence","year":"2015"},{"key":"10.1016\/j.ejps.2018.05.009_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0928-0987(02)00047-7","article-title":"Synthesis of analogs of l-valacyclovir and determination of their substrate activity for the oligopeptide transporter in Caco-2 cells","volume":"16","author":"Friedrichsen","year":"2002","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.05.009_bb0065","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijpharm.2012.05.069","article-title":"Influence of skin model on in vitro performance of drug-loaded soluble microneedle arrays","volume":"434","author":"Garland","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.05.009_bb0070","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0190-9622(86)70165-5","article-title":"Oral acyclovir for episodic treatment of recurrent genital herpes. Efficacy and safety","volume":"15","author":"Goldberg","year":"1986","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejps.2018.05.009_bb0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-5945-9-3","article-title":"Evaluation of the in vitro skin permeation of antiviral drugs from penciclovir 1% cream and acyclovir 5% cream used to treat herpes simplex virus infection","volume":"9","author":"Hasler-Nguyen","year":"2009","journal-title":"BMC Dermatol."},{"key":"10.1016\/j.ejps.2018.05.009_bb0080","series-title":"2016","first-page":"8","author":"Hassan","year":"2016"},{"key":"10.1016\/j.ejps.2018.05.009_bb0085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejps.2006.05.011","article-title":"Feasibility of microneedles for percutaneous absorption of insulin","volume":"29","author":"Ito","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.05.009_bb0090","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3109\/03639045.2011.576426","article-title":"Two-layered dissolving microneedles for percutaneous delivery of sumatriptan in rats","volume":"37","author":"Ito","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2018.05.009_bb0095","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1248\/bpb.b14-00406","article-title":"Application of dissolving microneedles to glucose monitoring through dermal interstitial fluid","volume":"37","author":"Ito","year":"2014","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejps.2018.05.009_bb0100","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0168-3659(01)00395-9","article-title":"Topical application of acyclovir-loaded microparticles: quantification of the drug in porcine skin layers","volume":"75","author":"de Jalon","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2018.05.009_bb0105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0939-6411(99)00075-2","article-title":"Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin","volume":"49","author":"Jenning","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2018.05.009_bb0110","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/j.1468-3083.2008.02761.x","article-title":"Randomized clinical study comparing Compeed cold sore patch to acyclovir cream 5% in the treatment of herpes simplex labialis","volume":"22","author":"Karlsmark","year":"2008","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.ejps.2018.05.009_bb0115","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2014.05.042","article-title":"A proposed model membrane and test method for microneedle insertion studies","volume":"472","author":"Larra\u00f1eta","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.05.009_bb0120","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1016\/j.biomaterials.2011.01.014","article-title":"Dissolving microneedles for transdermal drug administration prepared by stepwise controlled drawing of maltose","volume":"32","author":"Lee","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2018.05.009_bb0125","doi-asserted-by":"crossref","first-page":"8952","DOI":"10.1016\/j.actbio.2013.06.029","article-title":"Dissolving polymer microneedle patches for rapid and efficient transdermal delivery of insulin to diabetic rats","volume":"9","author":"Ling","year":"2013","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejps.2018.05.009_bb0130","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1002\/jps.10245","article-title":"Preliminary pharmacokinetic study of different preparations of acyclovir with beta-cyclodextrin","volume":"91","author":"Luengo","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.05.009_bb0135","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s13346-015-0237-z","article-title":"Microneedle characterisation: the need for universal acceptance criteria and GMP specifications when moving towards commercialisation","volume":"5","author":"Lutton","year":"2015","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2018.05.009_bb0140","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000211316","article-title":"Plasma and cutaneous drug levels after topical application of piroxicam gel: a study in healthy volunteers","volume":"7","author":"Marks","year":"1994","journal-title":"Skin Pharmacol."},{"key":"10.1016\/j.ejps.2018.05.009_bb0145","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2014.02.007","article-title":"Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs","volume":"180","author":"McCrudden","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2018.05.009_bb0150","doi-asserted-by":"crossref","first-page":"310","DOI":"10.5847\/wjem.j.1920-8642.2011.04.013","article-title":"Oral acyclovir induced acute renal failure","volume":"2","author":"Meng","year":"2011","journal-title":"World J Emerg Med"},{"key":"10.1016\/j.ejps.2018.05.009_bb0155","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000401274","article-title":"The skin of domestic mammals as a model for the human skin, with special reference to the domestic pig","volume":"7","author":"Meyer","year":"1978","journal-title":"Curr. Probl. Dermatol."},{"issue":"Suppl B","key":"10.1016\/j.ejps.2018.05.009_bb0160","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jac\/12.suppl_B.29","article-title":"Pharmacokinetics of acyclovir after intravenous and oral administration","volume":"12","author":"de Miranda","year":"1983","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejps.2018.05.009_bb0165","first-page":"197","article-title":"In vitro methods for the biopharmaceutical evaluation of topical formulations","volume":"36","author":"Neubert","year":"1990","journal-title":"Acta Pharm. Technol."},{"key":"10.1016\/j.ejps.2018.05.009_bb0170","first-page":"1683","article-title":"Treatment and prevention of herpes labialis","volume":"54","author":"Opstelten","year":"2008","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.ejps.2018.05.009_bb0175","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/1523-1747.ep12456948","article-title":"Acyclovir bioavailability in human skin","volume":"98","author":"Parry","year":"1992","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.ejps.2018.05.009_bb0180","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1773-2247(07)50049-3","article-title":"Elastic positively-charged liposomes for topical administration of acyclovir","volume":"17","author":"Peira","year":"2007","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ejps.2018.05.009_bb0185","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1517\/17425247.2014.938635","article-title":"The role of microneedles for drug and vaccine delivery","volume":"11","author":"Quinn","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2018.05.009_bb0190","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1079-2104(98)90398-5","article-title":"Oral acyclovir in prevention of herpes labialis: a randomized, double-blind, multi-centered clinical trial","volume":"85","author":"Raborn","year":"1998","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"10.1016\/j.ejps.2018.05.009_bb0195","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.oooo.2011.10.010","article-title":"Effectiveness of antiviral agents for the prevention of recurrent herpes labialis: a systematic review and meta-analysis","volume":"113","author":"Rahimi","year":"2012","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"10.1016\/j.ejps.2018.05.009_bb0200","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.semarthrit.2015.11.007","article-title":"Efficacy and safety of topical NSAIDs in the management of osteoarthritis: evidence from real-life setting trials and surveys","volume":"45","author":"Rannou","year":"2016","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.ejps.2018.05.009_bb0205","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejps.2017.11.031","article-title":"Dissolving polyvinylpyrrolidone-based microneedle systems for in-vitro delivery of sumatriptan succinate","volume":"114","author":"Ronnander","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.05.009_bb0210","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/0003-4819-118-4-199302150-00004","article-title":"Oral acyclovir to suppress frequently recurrent herpes labialis: a double-blind, placebo-controlled trial","volume":"118","author":"Rooney","year":"1993","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejps.2018.05.009_bb0215","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1600-0846.2010.00490.x","article-title":"Acyclovir skin depot characterization following in vivo iontophoretic delivery","volume":"17","author":"Siddoju","year":"2011","journal-title":"Skin Res. Technol."},{"key":"10.1016\/j.ejps.2018.05.009_bb0220","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000029928","article-title":"The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations-an overview","volume":"13","author":"Simon","year":"2000","journal-title":"Skin Pharmacol. Appl. Ski. Physiol."},{"key":"10.1016\/j.ejps.2018.05.009_bb0225","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/jac\/21.5.657","article-title":"The use of in-vitro sensitivity testing to predict clinical response of recurrent herpes simplex to suppressive oral acyclovir","volume":"21","author":"Smith","year":"1988","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejps.2018.05.009_bb0230","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0002-9343(82)90115-2","article-title":"Topical 5 percent acyclovir in polyethylene glycol for herpes simplex labialis. Antiviral effect without clinical benefit","volume":"73","author":"Spruance","year":"1982","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejps.2018.05.009_bb0235","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1001\/jama.1988.03410110105036","article-title":"Acyclovir prevents reactivation of herpes simplex labialis in skiers","volume":"260","author":"Spruance","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.ejps.2018.05.009_bb0240","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejpb.2016.05.023","article-title":"Anti-cancer activity of doxorubicin-loaded liposomes co-modified with transferrin and folic acid","volume":"105","author":"Sriraman","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2018.05.009_bb0245","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0168-3659(98)00060-1","article-title":"Methods for quantitative determination of drug localized in the skin","volume":"56","author":"Touitou","year":"1998","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2018.05.009_bb0250","series-title":"CEN Case Reports","first-page":"38","article-title":"Acute kidney injury due to acyclovir","volume":"2","author":"Yildiz","year":"2013"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718302288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718302288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:48:36Z","timestamp":1760528916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098718302288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":50,"alternative-id":["S0928098718302288"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2018.05.009","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dissolving polymeric microneedle arrays for enhanced site-specific acyclovir delivery","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2018.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}